Kang MJ - Search Results

1

Post-translational modification of OCT4 in breast cancer tumorigenesis.

Cho Y, Kang HG, Kim SJ, Lee S, Jee S, Ahn SG, Kang MJ, Song JS, Chung JY, Yi EC, Chun KH. Cho Y, et al. Among authors: kang mj, kang hg. Cell Death Differ. 2018 Nov;25(10):1781-1795. doi: 10.1038/s41418-018-0079-6. Epub 2018 Mar 6. Cell Death Differ. 2018. PMID: 29511337 Free PMC article.

2

Correction to: Post-translational modification of OCT4 in breast cancer tumorigenesis.

Cho Y, Kang HG, Kim SJ, Lee S, Jee S, Ahn SG, Kang MJ, Song JS, Chung JY, Yi EC, Chun KH. Cho Y, et al. Among authors: kang mj, kang hg. Cell Death Differ. 2020 May;27(5):1743. doi: 10.1038/s41418-019-0439-x. Cell Death Differ. 2020. PMID: 31641242 Free PMC article.

3

Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells.

Kang MJ, Kim HP, Lee KS, Yoo YD, Kwon YT, Kim KM, Kim TY, Yi EC. Kang MJ, et al. Proteomics. 2013 May;13(10-11):1714-25. doi: 10.1002/pmic.201200511. Epub 2013 Apr 23. Proteomics. 2013. PMID: 23554123

4

Crucial role of calbindin-D28k in the pathogenesis of Alzheimer's disease mouse model.

Kook SY, Jeong H, Kang MJ, Park R, Shin HJ, Han SH, Son SM, Song H, Baik SH, Moon M, Yi EC, Hwang D, Mook-Jung I. Kook SY, et al. Among authors: kang mj. Cell Death Differ. 2014 Oct;21(10):1575-87. doi: 10.1038/cdd.2014.67. Epub 2014 May 23. Cell Death Differ. 2014. PMID: 24853300 Free PMC article.

5

Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody.

Kim JG, Kang MJ, Yoon YK, Kim HP, Park J, Song SH, Han SW, Park JW, Kang GH, Kang KW, Oh DY, Im SA, Bang YJ, Yi EC, Kim TY. Kim JG, et al. Among authors: kang mj, kang kw, kang gh. PLoS One. 2012;7(3):e33322. doi: 10.1371/journal.pone.0033322. Epub 2012 Mar 16. PLoS One. 2012. PMID: 22438913 Free PMC article.

6

A point mutation in the heavy chain complementarity-determining region 3 (HCDR3) significantly enhances the specificity of an anti-ROS1 antibody.

Lee HK, Jin J, Kim SI, Kang MJ, Yi EC, Kim JE, Park JB, Kim H, Chung J. Lee HK, et al. Among authors: kang mj. Biochem Biophys Res Commun. 2017 Nov 4;493(1):325-331. doi: 10.1016/j.bbrc.2017.09.023. Epub 2017 Sep 6. Biochem Biophys Res Commun. 2017. PMID: 28888985

7

The N-recognin UBR4 of the N-end rule pathway is targeted to and required for the biogenesis of the early endosome.

Kim ST, Lee YJ, Tasaki T, Mun SR, Hwang J, Kang MJ, Ganipisetti S, Yi EC, Kim BY, Kwon YT. Kim ST, et al. Among authors: kang mj. J Cell Sci. 2018 Sep 10;131(17):jcs217646. doi: 10.1242/jcs.217646. J Cell Sci. 2018. PMID: 30111582

8

The N-recognin UBR4 of the N-end rule pathway is required for neurogenesis and homeostasis of cell surface proteins.

Kim ST, Lee YJ, Tasaki T, Hwang J, Kang MJ, Yi EC, Kim BY, Kwon YT. Kim ST, et al. Among authors: kang mj. PLoS One. 2018 Aug 29;13(8):e0202260. doi: 10.1371/journal.pone.0202260. eCollection 2018. PLoS One. 2018. PMID: 30157281 Free PMC article.

9

O-GlcNAc stabilizes SMAD4 by inhibiting GSK-3β-mediated proteasomal degradation.

Kim YJ, Kang MJ, Kim E, Kweon TH, Park YS, Ji S, Yang WH, Yi EC, Cho JW. Kim YJ, et al. Among authors: kang mj. Sci Rep. 2020 Nov 16;10(1):19908. doi: 10.1038/s41598-020-76862-0. Sci Rep. 2020. PMID: 33199824 Free PMC article.

10

Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line.

Lee YY, Kim HP, Kang MJ, Cho BK, Han SW, Kim TY, Yi EC. Lee YY, et al. Among authors: kang mj. Exp Mol Med. 2013 Nov 22;45(11):e64. doi: 10.1038/emm.2013.115. Exp Mol Med. 2013. PMID: 24263233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,512 results

Search Page

Filters